These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16954290)

  • 1. Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia.
    Klekner A; Bagyi K; Bognar L; Gaspar A; Andrasi M; Szabo J
    J Clin Microbiol; 2006 Sep; 44(9):3418-21. PubMed ID: 16954290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
    Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
    Kollef MH; Nováček M; Kivistik Ü; Réa-Neto Á; Shime N; Martin-Loeches I; Timsit JF; Wunderink RG; Bruno CJ; Huntington JA; Lin G; Yu B; Butterton JR; Rhee EG
    Lancet Infect Dis; 2019 Dec; 19(12):1299-1311. PubMed ID: 31563344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
    Robert R; Grollier G; Doré P; Hira M; Ferrand E; Fauchère JL
    J Crit Care; 1999 Sep; 14(3):114-9. PubMed ID: 10527248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
    Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Sun HK; Kuti JL; Nicolau DP
    Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients.
    Husni RN; Goldstein LS; Arroliga AC; Hall GS; Fatica C; Stoller JK; Gordon SM
    Chest; 1999 May; 115(5):1378-82. PubMed ID: 10334156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of endotracheal tube biofilm by nebulised gentamicin.
    Adair CG; Gorman SP; Byers LM; Jones DS; Feron B; Crowe M; Webb HC; McCarthy GJ; Milligan KR
    Intensive Care Med; 2002 Apr; 28(4):426-31. PubMed ID: 11967596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of etiological diagnosis of nosocomial pneumonia.
    Carvalho EM; Massarollo PC; Levin AS; Isern MR; Pereira WL; Abdala E; Rossi F; Mies S
    Braz J Infect Dis; 2008 Feb; 12(1):67-74. PubMed ID: 18553018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
    Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
    Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis.
    Hill SL; Bilton D; Johnson MM; Pye A; Mitchell JL; Stockley RA
    J Antimicrob Chemother; 1994 Jan; 33(1):129-36. PubMed ID: 8157553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM; Perry CM
    Am J Respir Med; 2003; 2(1):75-107. PubMed ID: 14720024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
    Saux P; Martin C; Mallet MN; Papazian L; Bruguerolle B; De Micco P; Gouin F
    Antimicrob Agents Chemother; 1994 Apr; 38(4):901-4. PubMed ID: 8031070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
    Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
    Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):408-13. PubMed ID: 9699393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
    Sokolova VI; Sanadze AG; Sychev DA; Babarina MB; Zaĭkov DA
    Antibiot Khimioter; 2014; 59(1-2):20-3. PubMed ID: 25051712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.